Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
225
NCT04073498
The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 14, 2019
Completion: Sep 26, 2024
NCT05605678
Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5)
Phase: N/A
Start: Dec 9, 2022
Completion: Nov 29, 2024
NCT05789524
The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B
Phase: Phase 2
Start: Jul 6, 2023
Completion: Feb 28, 2025
NCT05789537
A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors
Start: Jul 28, 2023
Completion: Feb 24, 2025
NCT06568302
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
Phase: Phase 3
Start: Jul 11, 2024
Completion: Jan 29, 2025